Eosinophil derived neurotoxin Antibody (C9)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41840
Key Product Details
Species Reactivity
Human, Porcine
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # C9
Concentration
1 mg/ml
Product Specifications
Immunogen
Immunized with recombinant Human Eosinophil derived neurotoxin (Uniprot#: P10153; Lys28-Ile161 (Uniprot#: P10153)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Eosinophil derived neurotoxin Antibody (C9)
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
5-20ug/mL
Immunohistochemistry
5-20ug/mL
Western Blot
0.5-2ug/mL
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
0.01M PBS, pH7.4, 50% glycerol
Preservative
0.05% Proclin 300
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: RNase2/EDN
Long Name
Eosinophil-Derived Neurotoxin
Alternate Names
RAF3, RNASE2, RNS2
Gene Symbol
RNASE2
Additional RNase2/EDN Products
Product Documents for Eosinophil derived neurotoxin Antibody (C9)
Product Specific Notices for Eosinophil derived neurotoxin Antibody (C9)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...